GAM Systematic’s Chemours CC Stock Holding History

GAM Systematic’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,219	Closed	-$46K	–	578
2017 Q2	$46K	Buy	1,219 +437	+56%	+$17.2K	0.01%	556
2017 Q1	$30K	Buy	+782	New	+$23.5K	0.01%	574

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GAM Systematic's CC Position: Q3 2017 in Review

GAM Systematic sold out of Chemours (CC) in Q3 2017, closing a stake of 1,219 shares — an estimated $46K sold.

GAM Systematic first reported a position in CC in Q1 2017 and held it in 2 quarters. The position peaked at $46K in Q2 2017. 499 funds tracked by Wall St. Rank hold CC as of Q3 2017.

GAM Systematic reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
GAM Systematic sold 1,219 Chemours shares in Q3 2017, an estimated $46K.
GAM Systematic first reported a position in Chemours in Q1 2017 and held it in 2 quarters.
GAM Systematic's Chemours position peaked at $46K in Q2 2017.
499 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.